CYSTIC FIBROSIS GENOTYPING ASSAY, MODEL 6L20-01

System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection

CELERA DIAGNOSTICS

The following data is part of a premarket notification filed by Celera Diagnostics with the FDA for Cystic Fibrosis Genotyping Assay, Model 6l20-01.

Pre-market Notification Details

Device IDK062028
510k NumberK062028
Device Name:CYSTIC FIBROSIS GENOTYPING ASSAY, MODEL 6L20-01
ClassificationSystem, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection
Applicant CELERA DIAGNOSTICS 1401 HARBOR BAY PKWY. Alameda,  CA  94502
ContactVictoria Mackinnon
CorrespondentVictoria Mackinnon
CELERA DIAGNOSTICS 1401 HARBOR BAY PKWY. Alameda,  CA  94502
Product CodeNUA  
CFR Regulation Number866.5900 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-07-18
Decision Date2007-09-07
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.